Skip to content

Carbonic Anhydrase II Responses to Basketball-Specific High-Intensity Interval Training

Erythrocyte Carbonic Anhydrase II as a Marker of Metabolic Adaptation to Basketball-Specific High-Intensity Interval Training

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07377851
Acronym
CAII-BASKET
Enrollment
24
Registered
2026-01-30
Start date
2025-11-01
Completion date
2026-01-15
Last updated
2026-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Adaptation to High-Intensity Interval Training

Keywords

Carbonic Anhydrase II, Exercise Physiology, Metabolic Adaptation, High-Intensity Interval Training, Basketball Training

Brief summary

This study aims to examine whether erythrocyte carbonic anhydrase II can be used as a biological marker of metabolic adaptation to basketball-specific high-intensity interval training. Carbonic anhydrase II is an enzyme involved in acid-base balance and carbon dioxide transport, and it may reflect physiological adaptations to intense exercise. Healthy basketball players participated in a structured high-intensity interval training program designed to reflect the physical demands of basketball. Blood samples and performance-related measurements were collected before and after the training period to evaluate changes in erythrocyte carbonic anhydrase II levels and related metabolic responses. The findings of this study are expected to improve the understanding of exercise-induced metabolic adaptations and to explore the potential use of erythrocyte carbonic anhydrase II as a practical biomarker for monitoring training responses in basketball players.

Detailed description

This study was designed to investigate erythrocyte carbonic anhydrase II as a potential biomarker of metabolic adaptation to basketball-specific high-intensity interval training. Carbonic anhydrase II plays a key role in acid-base regulation and carbon dioxide transport, which are critical physiological processes during repeated high-intensity exercise. Participants were healthy basketball players who completed a structured high-intensity interval training program reflecting the intermittent and high-demand nature of basketball activity. The training protocol consisted of repeated bouts of intense exercise interspersed with short recovery periods, consistent with established basketball-specific conditioning practices. Blood samples were obtained at predefined time points to assess erythrocyte carbonic anhydrase II levels. These biochemical measurements were evaluated alongside selected performance and physiological indicators to characterize training-induced metabolic adaptations. All assessments were conducted under standardized conditions to minimize variability related to diet, hydration, and recent physical activity. The study followed an observational pre-post design without clinical intervention beyond the prescribed training program. No experimental drugs or medical devices were used. Safety monitoring was conducted throughout the study period, and no serious adverse events were anticipated given the low-risk nature of the exercise protocol and the healthy status of the participants. This study seeks to contribute to the growing body of research on exercise-related biomarkers by examining whether erythrocyte carbonic anhydrase II may provide practical insight into metabolic adaptation to sport-specific high-intensity training.

Interventions

BEHAVIORALBasketball-Specific High-Intensity Interval Training

A structured basketball-specific high-intensity interval training program consisting of repeated bouts of intense exercise interspersed with short recovery periods, designed to induce metabolic adaptations.

Sponsors

Karamanoğlu Mehmetbey University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Masking description

No additional parties were masked. The study was conducted as an open-label trial.

Eligibility

Sex/Gender
MALE
Age
18 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

Healthy male and female basketball players aged 18 years or older Actively participating in regular basketball training at the time of the study Free from known cardiovascular, metabolic, or respiratory diseases No musculoskeletal injury that could limit participation in high-intensity exercise Willingness to participate in a basketball-specific high-intensity interval training program Ability to provide written informed consent

Exclusion criteria

Presence of any diagnosed cardiovascular, metabolic, or respiratory disease Use of medications or supplements known to affect metabolic or acid-base balance Acute or chronic musculoskeletal injury within the previous three months Participation in another structured training or research intervention during the study period Failure to comply with the training protocol or assessment procedures

Design outcomes

Primary

MeasureTime frameDescription
Change in Erythrocyte Carbonic Anhydrase II LevelsBaseline( week 0) and post training (week 8)The primary outcome is the change in erythrocyte carbonic anhydrase II levels measured before and after the basketball-specific high-intensity interval training program. Erythrocyte carbonic anhydrase II was assessed from blood samples as an indicator of metabolic adaptation to high-intensity exercise.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026